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doi:10.1016/j.fjs.2012.05.002Summary Primary leiomyosarcoma of the kidney is an extremely rare disease. No single case
of primary renal leiomyosarcoma was reported at National Taiwan University Hospital during
1995e2010. Here, we report the case of a 74-year-old woman who presented with intermittent
lower abdominal pain for 2 months. A heterogeneous tumor was found in the left kidney. The
clinical presentation suggested renal cell carcinoma. A diagnosis of leiomyosarcoma was made
based on the pathological examination. The patient underwent radical nephrectomy. No
distant metastasis was noted. No adjuvant chemotherapy or radiotherapy was provided after
surgery.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Primary leiomyosarcoma of the kidney is an extremely rare
disease. No single case of primary renal leiomyosarcoma
was reported at National Taiwan University Hospital during
1995e2010. The largest reported case series includes 27
cases that were collected from 1986e2009 from three
cancer centers in the United States (Johns Hopkins
Hospital, Cleveland Clinics, and the Anderson Cancer
Center). Here, we report the case of a 74-year-old woman
who presented with intermittent lower abdominal pain for
2 months. A heterogeneous tumor was found in the leftm.tw (S.-M. Wang).
ight ª 2012, Taiwan Surgical Assokidney. Correct diagnosis was reached only after histolog-
ical and immunohistochemical analysis.
2. Case report
A 74-year-old woman visited our outpatient clinic in 2011.
She complained of dull intermittent lower abdominal pain
that had presented for 2 months. The pain was unrelated to
diet. Nausea, vomiting, diarrhea, and tarry stool were
absent. The patient had not traveled within the previous 3
months. Her medical records described one episode of
coronary artery disease that had presented 8 years prior
and regular treatment for hypertension. Her baseline
systolic blood pressure was 120e140 mmHg. On physical
examination, her vital signs were stable and there were no
peritoneal signs. Laboratory data were also normal.ciation. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Heterogeneous tumor (8.3  5.9 cm) at the lower
pole of the left kidney. It can be seen that the tumor has
invaded the perirenal fat, but did not extend beyond Gerota’s
fascia.
Figure 3 Spindle tumor cells with high cellularity and atyp-
ical mitosis (arrows). Most tumor cells have blunt-ended nuclei
and eosinophilic cytoplasm (400).
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pain, an abdominal ultrasound was conducted which
showed a hypoechoic tumor in the left kidney. A computed
tomography (CT) scan revealed a large heterogeneous
tumor (8.3  5.9 cm) at the lower pole of the left kidney
that was invading into the perirenal fat but not extending
beyond Gerota’s fascia (Fig. 1). Lymphadenopathy and
venous thrombosis were absent. A bone scan revealed the
absence of bone metastasis. Based on the tentative diag-
nosis of renal cell carcinoma (cT2N0M0), a retroperitoneal
laparoscopic radical nephrectomy was performed.
On hemisection of the kidney, a firm tumor measuring
8  6 cm with a whitish gray whorled appearance was foundFigure 2 A firm tumor measuring 10  8  6 cm with
a whitish gray whorled appearance located at the lower pole of
the left kidney.in the lower pole of the left kidney (Fig. 2). The major renal
vessels, lymph nodes, and ureter were grossly disease-free.
Upon microscopic examination, the tumor was found to
have spindle cells with a degree of high cellularity and an
interlacing fascicular pattern. Most tumor cells generally
had blunt-ended nuclei and eosinophilic cytoplasm (Fig. 3).
Nuclear atypia and even bizarre giant tumor cells were
occasionally seen as well.
Immunohistochemical analysis showed that the tumor
cells were diffusely positive for smooth muscle actin
(Fig. 4), focally positive for desmin (Fig. 5), and negative
for cytokeratin, c-kit, and HMB45. According to the scoring
system of the French Federation of Cancer Centers, scores
of 1 were assigned for tumor differentiation, necrosis, and
mitosis. A total score of 3 was therefore recorded, defining
this as a grade I tumor.
Based on these findings, the final diagnosis of primary
renal leiomyosarcoma was made. No adjuvant chemo-
therapy or radiotherapy was provided after surgery. The
patient underwent whole-body magnetic resonance
imaging (MRI) 1 month after surgery, which revealed no
distant metastasis or lymphadenopathy.Figure 4 Tumor cells are diffusely positive for smooth
muscle actin (400).
Figure 5 Tumor cells are focally positive for desmin (dark
brown; 400).
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Leiomyosarcoma is a malignant tumor that arises from the
smooth muscle components of the soft tissue and
commonly occurs in the retroperitoneum. However,
primary renal leiomyosarcoma is rare in the kidney.1 It can
occur in the renal capsule, pelvis, parenchyma, and renal
vessels. There is predominance in female, with most cases
diagnosed in the fourth to sixth decades of life.2 The mean
tumor size at the time of diagnosis is 13.4 cm, and about
60% of tumors are located on the right kidney.2 The most
common clinical presentations are an abdominal mass (with
or without tenderness) that is accompanied by hematuria
and, less frequently, weight loss and gastrointestinal
symptoms.3 Its usual appearance on CT is fibrous tissue with
a predominance of spindle cells. The fibrous tissue exhibits
low attenuation on early postcontrast CT and high attenu-
ation on delayed postcontrast CT. Conversely, the spindle
cell components of leiomyosarcoma exhibit high attenua-
tion on early postcontrast CT and low attenuation on
delayed postcontrast CT.4 Because of its nonspecific
symptoms and the potential confusion that can result from
imaging techniques, preoperative diagnosis is difficult. Fine
needle aspiration has been used in some cases.5
The light microscopic findings of leiomyosarcoma show
the typical morphology of smooth muscle tumors: alter-
nating fascicles of spindle cells with blunt-ended nuclei and
eosinophilic cytoplasm (Fig. 4). However, renal leiomyo-
sarcoma may also be confused with sarcomatoid renal cell
carcinoma on histological examination. Immunohisto-
chemical staining is then needed to differentiate between
the two entities.6 Leiomyosarcoma expresses smooth
muscle actin, calponin, desmin, and h-caldesmon and is
negative for cytokeratin, S-100 protein, and HMB45.
There is no specific grading system for primary renal
leiomyosarcoma, though the French Federation of Cancer
Centers classification system is often used. According to
this system, the tumor is given a score ranging from 1e3
depending on the degree of differentiation, a second scoreof 1e3 for the number of mitoses, and a third score of 0e2
for the degree of necrosis. A tumor with a total score of 2 or
3 is defined as a grade I tumor, 4 or 5 as a grade II tumor,
and 6e8 as a grade III tumor.7 Grade II and III tumors are
referred to as high-grade and demonstrate a poor clinical
prognosis.8 Unfortunately, most patients diagnosed with
leiomyosarcoma usually have high-grade tumors with local
invasion or distant metastasis.2,8 Metastasis is most
commonly seen in the lung.2
Radical nephrectomy is the standard treatment for
primary renal leiomyosarcoma.2,8 However, some urologists
and oncologists have advocated radical nephrectomy fol-
lowed by chemotherapy or radiotherapy because of the
aggressiveness of this form of cancer. David et al9
prescribed vincristine (1.4 mg/m2) or cyclophosphamide
(700 mg/m2) plus actinomycin D (0.4 mg/m2) to patients
following surgery, resulting in the abscence of distant
metastasis for 4 years. Despite such recommendations for
adjuvant chemotherapy and radiotherapy, these treat-
ments are still controversial.
In our case, only retroperitoneal laparoscopic radical
nephrectomy was performed. Due to the en bloc excision
and the absence of disease in the surrounding tissue, no
adjuvant chemotherapy or radiotherapy was administered.
The patient underwent a whole-body MRI 1 month after
surgery, which revealed no distant metastasis. Regular
follow-up image studies to identify distant metastases are
recommended by most specialists, and we tend to agree
with this recommendation.References
1. Venkatesh K, Lamba Saini M, Niveditha SR, Krishnagiri C, Babu S.
Primary leiomyosarcoma of the kidney. Pathol Res Int. 2010;
2010:652398.
2. Miller JS, Zhou M, Brimo F, Gou CC, Epstein JI. Primary leio-
myosarcoma of the kidney: a clinicopathologic study of 27
cases. Am J Surg Pathol. 2010;34:238e242.
3. Demir A, Yazici CM, Eren F, Turheri L. Case report: good prog-
nosis in leiomyosarcoma of kidney. Int Uro Nephrol. 2007;39:
7e10.
4. Ochiai K, Onitsuka H, Honda H, et al. Leiomyosarcoma of
kidney: CT and MR appearance. J Compur Assist Tomogr. 1993;
17:656e658.
5. Chou LT, Chan SK, Chou WH. Fine needle aspiration cytodiag-
nosis of leiomyosarcoma of the renal pelvis: a case report with
immunohistochemical study. Acta Cytol. 1994;38:759e763.
6. Moudouni SM, En-Nia I, Rioux-Leqlerq N, Guille F, Lobel B.
Leiomyosarcoma of the renal pelvis. Scand J Urol Nephrol. 2001;
35:425e427.
7. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of
the national cancer institute and French Federation of Cancer
Centers sarcoma group grading systems in a population of 410
adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15:
350e362.
8. Deyrup AT, Montgomery E, Fisher C. Leiomyosarcoma of the
kidney: a clinicopathologic study. Am J Surg Pathol. 2004;28:
178e182.
9. Beccia DJ, Elkort RJ, Krane RJ. Adjuvant chemotherapy in renal
leiomyosarcoma. Urology. 1979;13:652e654.
